Enfusion, Inc. Class A Common Stock (ENFN)
11.13
0.00 (0.00%)
Enfusion Inc is a technology company that provides a comprehensive investment management platform designed to streamline operations for asset managers, fund administrators, and financial institutions
Their services include portfolio management, trade execution, risk analytics, and reporting solutions, all of which are integrated into a single, cloud-based platform. By leveraging advanced technology and data analytics, Enfusion aims to enhance operational efficiency and improve decision-making for its clients in the rapidly evolving financial landscape.
Previous Close | 11.13 |
---|---|
Open | - |
Bid | 9.000 |
Ask | 17.69 |
Day's Range | N/A - N/A |
52 Week Range | 7.600 - 11.38 |
Volume | 1 |
Market Cap | - |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 1,199,450 |
News & Press Releases
Nutanix Stock Earns RS Rating Upgradeinvestors.com
The Relative Strength (RS) Rating for Nutanix stock entered a new percentile Wednesday, with a rise from 66 to 81.
Via Investor's Business Daily · January 29, 2025
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates LGTY, AZPN, ENFN on Behalf of Shareholders
NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
By Halper Sadeh LLC · Via GlobeNewswire · January 28, 2025
DigitalOcean Stock Gets RS Rating Upgradeinvestors.com
DigitalOcean stock had its Relative Strength Rating upgraded to 75 Monday — a nice improvement, but still shy of the preferred 80-plus score.
Via Investor's Business Daily · January 27, 2025
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Logility Supply Chain Solutions, Inc. (Nasdaq - LGTY), Enfusion, Inc. (NYSE - ENFN), Intra-Cellular Therapies, Inc. (Nasdaq - ITCI), Shutterstock, Inc. (NYSE - SSTK)
BALA CYNWYD, Pa., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
By Brodsky & Smith LLC · Via GlobeNewswire · January 27, 2025
Freshworks Stock Gets IBD Rating Upgrade To 96investors.com
Computer software Freshworks stock saw its IBD SmartSelect Composite Rating jump to 96 Friday, up from 93 the day before.
Via Investor's Business Daily · January 24, 2025
Top-Rated Stocks: DigitalOcean Sees Composite Rating Climb To 96investors.com
The revised score means DigitalOcean stock currently tops 96% of all other stocks in terms of key performance metrics and technical strength.
Via Investor's Business Daily · January 23, 2025
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN, ITCI, HEES, SSTK on Behalf of Shareholders
NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
By Halper Sadeh LLC · Via GlobeNewswire · January 21, 2025
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Enfusion, Inc. (NYSE - ENFN), Intra-Cellular Therapies, Inc. (Nasdaq - ITCI), H&E Equipment Services, Inc. (Nasdaq - HEES), Shutterstock, Inc. (NYSE - SSTK)
BALA CYNWYD, Pa., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
By Brodsky & Smith LLC · Via GlobeNewswire · January 21, 2025
12 Information Technology Stocks Moving In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · January 17, 2025
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN and EDBL on Behalf of Shareholders
NEW YORK, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
By Halper Sadeh LLC · Via GlobeNewswire · January 15, 2025
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN, ITCI, EDBL on Behalf of Shareholders
NEW YORK, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
By Halper Sadeh LLC · Via GlobeNewswire · January 13, 2025
ENFUSION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Enfusion, Inc. - ENFN
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Enfusion, Inc. (NYSEENFN) to Clearwater Analytics Holdings, Inc. NYSE: CWANNYSECWAN)
By Kahn Swick & Foti, LLC · Via Business Wire · January 13, 2025
ENFN Investors Have the Opportunity to Join Investigation of Enfusion, Inc. With the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Enfusion, Inc. (“Enfusion” or “the Company”) (NYSEENFN) for potential breaches of fiduciary duty on the part of its directors and management.
By The Schall Law Firm · Via Business Wire · January 13, 2025
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Enfusion, Inc. (NYSE - ENFN), Intra-Cellular Therapies, Inc. (Nasdaq - ITCI), Paycor HCM, Inc. (Nasdaq - PYCR), Accolade, Inc. (Nasdaq - ACCD)
BALA CYNWYD, Pa., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
By Brodsky & Smith LLC · Via GlobeNewswire · January 13, 2025
ENFN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Enfusion, Inc. Is Fair to Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Enfusion, Inc. (NYSEENFN) to Clearwater Analytics for $5.85 per share in cash and $5.40 per share in Clearwater Class A Common Stock is fair to Enfusion shareholders.
By Halper Sadeh LLC · Via Business Wire · January 13, 2025
Shareholder Alert: Ademi LLP Investigates Whether Enfusion, Inc. Is Obtaining a Fair Price for Its Public Shareholders
Ademi LLP is investigating Enfusion (NYSEENFN) for possible breaches of fiduciary duty and other violations of law in its transaction with Clearwater.
By Ademi LLP · Via Business Wire · January 13, 2025
Clearwater Analytics to Acquire Enfusion for $1.5 Billion Expanding its Investment Management Platform with Front-to-Back Capabilities
By Clearwater Analytics · Via Business Wire · January 13, 2025
This Analyst With 85% Accuracy Rate Sees Around 10% Upside In Alphabet - Here Are 5 Stock Picks For 2024 From Wall Street's Most Accurate Analystsbenzinga.com
Via Benzinga · January 2, 2025
This Analyst With 82% Accuracy Rate Sees Around 28% Upside In Apple - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analystsbenzinga.com
Via Benzinga · December 30, 2024
12 Information Technology Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · December 19, 2024
Fastly Stock Gets IBD Rating Upgradeinvestors.com
One key metric to look for in a stock is an 80-plus Relative Strength Rating. Fastly stock cleared that benchmark Tuesday, with a jump to 84.
Via Investor's Business Daily · December 17, 2024
Enfusion To Present at Upcoming Investor Events
Enfusion, Inc. ("Enfusion") (NYSEENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced that Enfusion’s Chief Financial Officer, Brad Herring, and Chief Operating Officer, Neal Pawar, will participate at the following investor events:
By Enfusion, Inc. · Via Business Wire · November 20, 2024
Enfusion Announces Third Quarter 2024 Results
Enfusion, Inc. ("Enfusion") (NYSEENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, has posted its third quarter 2024 financial results as part of its Q3 2024 Shareholder Letter which can be viewed by navigating to the Financials section of its Investor Relations website at http://ir.enfusion.com.
By Enfusion, Inc. · Via Business Wire · November 4, 2024
Enfusion Announces Key Leadership Team Additions to Drive Client Success and Fuel Innovation
Enfusion, Inc. (“Enfusion”) (NYSEENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, announced today the appointments of Arman Artuc to Head of Engineering and Jesper Cordes to Head of Client Services Americas. These additions to the leadership team reinforce the company’s position as a global leader in investment technology and services, which enables Enfusion to continue to attract top-performing industry experts and innovators to its ranks.
By Enfusion, Inc. · Via Business Wire · October 10, 2024
Enfusion Announces Date of Third Quarter 2024 Results
Enfusion, Inc. ("Enfusion") (NYSEENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced it will release its third quarter 2024 financial results before the U.S. financial markets open on Monday, November 4, 2024. Management will host a conference call and webcast that same morning at 8:30 AM (ET) / 5:30 AM (PT) to discuss the results.
By Enfusion, Inc. · Via Business Wire · October 3, 2024